Tolebrutinib, a novel BTK inhibitor that targets neuroinflammation, slowed disability progression by 31% in nrSPMS, a phase 3 ...

Me’s debacle should be a major wake-up call, reminding policymakers and all of us of the risks of giving access to our ...

A study aims to explore whether individuals eligible for lung cancer screening also access other preventive services.

Scientists discover how to rouse the immune system around "cold" tumors, making them vulnerable to cancer-killing immune ...

Coherus BioSciences, Inc.’s CHRS share price has dipped by 5.19%, which has investors questioning if this is right time to ...

During a live event, Megan Kruse, MD, discussed NCCN guidelines and key therapies for patients with HR-positive metastatic ...

One of the best ways to defeat cancer is by rousing the immune system to attack it.Experts have thought that immune cells had ...

Screening tests are critical in early detection because they can find cancer before symptoms appear, when treatment is more ...

Data from an open-label extension of VISIONARY-MS support an association between gold nanocrystals and neuronal repair and remyelination in patients with stable multiple sclerosis and visual deficits, ...

Sangamo Therapeutics, Inc.’s SGMO share price has dipped by 5.89%, which has investors questioning if this is right time to ...

A stem cell–based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for advanced Parkinson’s disease, according to results from a phase 1 clinical ...